Form D · Biotechnology
Reveal Biosensors, Inc.
San Jose, CA · CIK 0001721240
Offering snapshot reported Oct 31, 2017 · SEC filing
- Reported sold
- $225K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 28, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2017 | Initial | $225,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-297753
Convertible Promissory Notes
Source: Form D, filed Oct 31, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy M. Hatch | Director |
| Stephen G. Ursenbach | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5512 Livorno Court
San Jose, CA, 95138
San Jose, CA, 95138